HROW FY 2018 Earnings — Harrow Health, Inc. Revenue & Financial Results | Market Cap Arena

HROWHarrow Health, Inc.

$1B

FY 2018 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$41M+54.5% YoY

Gross Profit

$25M60.1% margin

Operating Income

-$5M-12.6% margin

Net Income

$15M35.3% margin

EPS (Diluted)

$0.61

Cash Flow

Operating Cash Flow

$687,000

Free Cash Flow

-$2M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$49M

Total Liabilities

$25M

Stockholders' Equity

$25M

Cash & Equivalents

$7M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$41M	$27M	+54.5%
Gross Profit	$25M	$13M	+87.3%
Operating Income	-$5M	-$12M	+57.1%
Net Income	$15M	-$12M	+222.0%